Daniel K. Spiegelman - Jun 6, 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Justin Hunter For: Daniel K. Spiegelman
Stock symbol: MYGN
Transactions as of: Jun 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/7/2024, 04:53 PM
Previous filing: Jun 4, 2024
Next filing: Jun 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						32.9K	Jun 6, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Daniel K. Spiegelman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a director of the Company, effective June 6, 2024, and therefore is no longer subject to Section 16 reporting